6.99
0.00
(0.00%)
As of 12:39:39 PM GMT+8. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jun Xu | GM & Director | -- | -- | 1964 |
| Mr. Leqi Chen | Financial Manager | -- | -- | 1987 |
| Mr. Zheng Liu | Deputy GM & Secretary of Board of Directors | -- | -- | 1970 |
| Mr. Ji Hui Shen | Deputy General Manager | -- | -- | 1966 |
| Mr. Hui Lu | Deputy General Manager | -- | -- | 1975 |
| Ms. Zhengmin Song | Deputy General Manager | -- | -- | 1968 |
| Ms. Xi Zhao | Head of Accounting | -- | -- | -- |
| Mr. Yang Gu M.D. | Director of Sales & Marketing | -- | -- | -- |
Shanghai RAAS Blood Products Co., Ltd.
No. 2009, Wangyuan Road
Fengxian District
Shanghai, 201401
China
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 3,254
Description
Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.
Corporate Governance
Shanghai RAAS Blood Products Co., Ltd.’s ISS Governance QualityScore as of April 1, 2025 is 4. The pillar scores are Audit: 8; Board: 5; Shareholder Rights: 4; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
September 30, 2024 at 12:00 AM UTC
Ex-Dividend Date